ArticleRMD open2019

Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis.

Desirée van der Heijde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.